← Back to Search

eHealth Intervention for Cancer (DUET Trial)

N/A
Waitlist Available
Led By Wendy Demark-Wahnefried, PhD, RD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

DUET Trial Summary

This trial will compare the effects of a diet and exercise program delivered through an interactive website and text messages to a control group who will not receive the intervention. The goal is to see if the intervention can reduce obesity and improve quality of life measures.

Eligible Conditions
  • Cancer
  • Obesity

DUET Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Body Weight
Secondary outcome measures
Barriers for increased physical activity
Barriers to Eating a Healthy Low Calorie Diet
Circulating Adiponectin
+27 more
Other outcome measures
Circulating Insulin (TSH)
Relationship to chosen partner
Socio-Demographic (George, et al, 1984)

DUET Trial Design

2Treatment groups
Experimental Treatment
Group I: Immediate Intervention GroupExperimental Treatment1 Intervention
Dyads randomized to the Immediate Intervention Group will receive a "Welcome Box" at completion of the baseline assessment. The Welcome Box will include two of each of the following: 1) Letters describing the project logistics and the important roles of each dyad member); 2) WiFi-enabled Scales (with instructions to weigh daily); 3) Portion Doctor ®Tableware (with instructions to use the portion plates at least once a day); 4) Fitbit® Inspire Activity Monitors (with instructions to share data with the dyad member and the study office); and 5) Instructions on how to create a secured account on the DUET website and instructions for logging on.
Group II: Delayed Intervention GroupExperimental Treatment1 Intervention
Participants assigned to the Delayed Intervention Group will receive a "Welcome Box" which on the outside is identical (and also is comparably weighted with bottled water) to that given to the Immediate Intervention group. This box would include: 1) Letters describing the project logistics and the important roles of each dyad member; and 2) monthly online study newsletters on topics unrelated to diet and exercise, but still of interest to cancer survivors and dyad members such as coping with stress, reducing exposure to radiation, sun safety, etc. to enhance retention and will be offered the opportunity to receive the online intervention after completing final 6-month assessments.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
eHealth Intervention
2016
N/A
~220

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,581 Previous Clinical Trials
2,277,917 Total Patients Enrolled
Wendy Demark-Wahnefried, PhD, RDPrincipal Investigator - University of Alabama at Birmingham
University of Alabama at Birmingham
4 Previous Clinical Trials
721 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for this clinical trial still open?

"According to clinicaltrials.gov, this experiment is not currently taking on new recruits; the first posting was dated October 15th 2020 with a recent update being December 7th 2022. Despite that, there are 820 other studies actively seeking participants at present."

Answered by AI
Recent research and studies
NutrientsJournal
Rationale and Methods for a Randomized Controlled Trial of a Dyadic, Web-based, Weight Loss Intervention Among Cancer Survivors and Partners: The DUET Study
Pekmezi, Dorothy, Tracy Crane, Robert Oster, Laura Rogers, Teri Hoenemeyer, David Farrell, William Cole, Kathleen Wolin, Hoda Badr, and Wendy Demark-Wahnefried. 2021. “Rationale and Methods for a Randomized Controlled Trial of a Dyadic, Web-based, Weight Loss Intervention Among Cancer Survivors and Partners: The DUET Study”. Nutrients. MDPI AG. doi:10.3390/nu13103472.
NutrientsJournal
Rationale and Methods for a Randomized Controlled Trial of a Dyadic, Web-based, Weight Loss Intervention Among Cancer Survivors and Partners: The DUET Study
Pekmezi, Dorothy, Tracy Crane, Robert Oster, Laura Rogers, Teri Hoenemeyer, David Farrell, William Cole, Kathleen Wolin, Hoda Badr, and Wendy Demark-Wahnefried. 2021. “Rationale and Methods for a Randomized Controlled Trial of a Dyadic, Web-based, Weight Loss Intervention Among Cancer Survivors and Partners: The DUET Study”. Nutrients. MDPI AG. doi:10.3390/nu13103472.
clinicaltrials.govStudy
Daughters, dUdes, Mothers and othErs Fighting Cancer Together
Wendy Demark-Wahnefried, PhD 2020. "Daughters, dUdes, Mothers and othErs Fighting Cancer Together". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04132219.
~25 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top